首页 > 市场调查报告书 > 製药

基因治疗学和RNAi 以基因为基之药物开发

市场调查报告书

商品编码

1378556

Crispr 和 Cas Gene 市场：按产品类型、按应用、按最终用户、按地区

Crispr and Cas Gene Market, By Product Type, By Application, By End User, By Region

出版日期: 2023年09月26日 | 出版商:

Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计到 2023 年，全球 Crispr 和 Cas 基因市场将达到 15.4 亿美元，预计在预测期内（2023-2030 年）CAGR为 22.8%。

报告范围		报告详情
基准年	2022年	2023年市场规模	15.4亿美元
实绩资料	2018-2021	预测期	2023-2030
预测期CAGR	22.80%	2030年市场规模预测	64.7亿美元

图 1. Crispr 和 Cas 基因的全球市场占有率(%)（依产品类型），2023 年

成簇的规则间隔的短回文重复序列称为 CRISPR。 CRISPR 是将细菌免疫系统的 DNA 切割元件转化为基因编辑工具。该系统的两个关键组件是引导 Cas 核酸酶到达其标靶的引导 RNA 序列 (gRNA) 和结合并切割 DNA 的 CRISPR 相关 (Cas) 核酸酶。 CRISPR 是在细菌的免疫系统中发现的，它可以让噬菌体切割和破坏入侵病毒的 DNA。在其 DNA 切割能力的分子基础被确定后，CRISPR 迅速发展成为编辑基因组的工具。 CRISPR 很重要，因为它允许研究人员改变几乎任何生物体的遗传密码。与先前的基因编辑方法相比，CRISPR更简单、更便宜、更准确。它还具有多种实际应用，例如开发耐旱作物和纠正遗传疾病。在细菌和古细菌中，适应性免疫是基于 CRISPR 系统。细菌和古细菌的适应性免疫是基于 CRISPR 系统。 CRISPR 系统利用 Cas 核酸酶，即与 DNA 结合併导致双链(DSB) 的酵素。当病毒感染细菌时，原型间隔区（病毒 DNA 的片段）会被 Cas 核酸酶切割。该片段与先前感染的病毒的其他片段一起作为免疫记忆储存在细菌基因组中。将这些病毒间隔片段置于重复序列之间的间隔序列和回文重复序列赋予了 CRISPR 名称。

市场动态

Crispr 和 CAS 基因市场的主要参与者专注于开发创新产品，预计这将在预测期内推动市场成长。例如，2023 年 2 月 8 日，生物技术公司 Vertex Therapeutics 向美国食品药物管理局(FDA) 申请了第一个基于 CRISPR 的基因编辑疗法。

本研究的主要特点

本报告详细分析了全球CRISPR和CAS基因市场，并提供了以2022年为基准年的预测期（2023-2030）的市场规模和年复合成长率（CAGR）。
它还阐明了不同细分市场的潜在收益成长机会，并说明了该市场有吸引力的投资提案矩阵。
它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
这份研究报告根据公司亮点、产品系列、主要成就、财务实绩和策略等参数，介绍了全球 Crispr 和 Cas 基因市场的主要企业。
本研究涵盖的主要企业包括 Thermo Fisher Scientific Inc.、Merck KGaA (Sigma-Aldrich)、OriGene Technologies, Inc.、New England Biolabs、Cellecta, Inc.、Agilent Technologies, Inc. 和 Applied StemCell, Inc.. Synthego、 Genscript、Mirus Bio LLC、Integrated DNA Technologies, Inc. 和Mammoth Biosciences, Inc.
该报告的见解使行销人员和公司负责人能够就未来的产品发布、升级、市场扩张和行销策略做出明智的资讯。
本报告针对该产业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
相关人员可以透过分析全球 Crispr 和 Cas Gene 市场时所使用的各种策略矩阵来促进决策。

公司简介
- Thermo Fisher Scientific Inc.
- Merck KGaA（Sigma-Aldrich）
- OriGene Technologies, Inc.
- New England Biolabs
- Cellecta, Inc.
- Agilent Technologies
- Applied StemCell, Inc.
- Synthego
- Genscript
- Mirus Bio LLC
- Integrated DNA Technologies, Inc.
- Mammoth Biosciences, Inc.
- Analysts'Views

第10章章

参考
调查方法

简介目录

Product Code: CMI2598

The global crispr and cas gene market is estimated to be valued at US$ 1.54 Billion in 2023 and is expected to exhibit a CAGR of 22.8 % during the forecast period (2023-2030).

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 1.54 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	22.80%	2030 Value Projection:	US$ 6.47 Bn

Figure 1. Global Crispr and Cas Gene Market Share (%), By Product Type, 2023

Clustered Regularly Interspaced Short Palindromic Repeats is known as CRISPR. It is a DNA-chopping element of bacterial immune systems that has been transformed into a gene editing tool. By following a configurable guide, it functions as a precise pair of molecular scissors that can cut a target DNA sequence.

A guide RNA sequence (gRNA), which leads the Cas nuclease to its target, and a CRISPR-associated (Cas) nuclease, which binds and breaks DNA, are the two essential components of the system. It was found in bacterial immune systems, where it destroys bacteriophage-invading viruses-by chopping off their DNA. It was swiftly created as a tool for editing genomes after the molecular basis for its DNA-cleaving ability was identified.

CRISPR is significant because it enables researchers to change practically any organism's genetic coding. In comparison to earlier gene editing methods, it is easier, less expensive, and more accurate. It also has a variety of practical applications, including as developing crops that can withstand drought and correcting genetic diseases.

In bacteria and archaea, adaptive immunity is based on the CRISPR system. It makes use of Cas nucleases, enzymes that can attach to DNA and cause double-stranded breaks (DSBs). A protospacer, a segment of viral DNA, gets cut off by the Cas nuclease when a virus infects a bacteria. This fragment, along with others from earlier infected viruses, is kept in the bacterial genome as an immunological memory. The arrangement of spacers and palindromic repeats that results in the placement of these viral spacer pieces between repetitive sequences is what gives CRISPR its name.

Market Dynamics

The key players in the crispr and cas gene market are focusing on the development of innovative products is expected to propel the market growth over the forecast period. For instance, on February 8, 2023, Vertex Therapeutics, a biotechnology company, submitted its first CRISPR-based gene editing therapy to the U.S. Food and Drug Administration (FDA).

Key features of the study:

This report provides an in-depth analysis of the global crispr and cas gene market and provides market size (US$ Billion) and Compound Annual Growth Rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
The study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global crispr and cas gene market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
The key companies covered as a part of this study include Thermo Fisher Scientific Inc., Merck KGaA (Sigma-Aldrich), OriGene Technologies, Inc., New England Biolabs, Cellecta, Inc., Agilent Technologies, Inc., Applied StemCell, Inc., Synthego, Genscript, Mirus Bio LLC, Integrated DNA Technologies, Inc., and Mammoth Biosciences, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global crispr and cas gene market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global crispr and cas gene market

Global Crispr and Cas Gene Market Detailed Segmentation:

By Product Type:
- Vector-based Cas
- DNA-free Cas
- Others
By Application:
- Genome Engineering
- Disease Models
- Functional Genomics
- Knockdown/Activation
- Others
By End User:
- Biotechnology and Pharmaceutical Companies
- Academic & Government Research Institutes
- Contract Research Organizations
By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Company Profiles
- Thermo Fisher Scientific Inc.
- Merck KGaA (Sigma-Aldrich)
- OriGene Technologies, Inc.
- New England Biolabs
- Cellecta, Inc.
- Agilent Technologies
- Applied StemCell, Inc
- Synthego
- Genscript
- Mirus Bio LLC
- Integrated DNA Technologies, Inc.
- Mammoth Biosciences, Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Application
- Market Snippet, By End User
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Recent Trends
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis
PORTER's Analysis

4. Global Crispr And Cas Gene Market - COVID-19 Impact Analysis

Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand

5. Global Crispr And Cas Gene Market, By Product Type, 2018 - 2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Vector-based Cas
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
DNA-free Cas
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends

6. Global Crispr And Cas Gene Market, By Application, 2018 - 2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Genome Engineering
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Disease Models
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Functional Genomics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Knockdown/Activation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends

7. Global Crispr And Cas Gene Market, By End User, 2018 - 2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Biotechnology and Pharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Academic & Government Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Contract Research Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)

8. Global Crispr And Cas Gene Market, By Region, 2018 - 2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
North America
- Market Size and Forecast, Y-o-Y Growth, By Product Type, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth, By Application, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth, By End User, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth, By Country, 2018 -2030, (US$ Bn)
U.S.
Canada
Europe
- Market Size and Forecast, Y-o-Y Growth, By Product Type, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth, By Application, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth, By End User, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth, By Country, 2018 -2030, (US$ Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Market Size and Forecast, Y-o-Y Growth and By Product Type, 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Application, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By End User, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
- Market Size and Forecast, Y-o-Y Growth, By Product Type, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth, By Application, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth, By End User, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth, By Country, 2018 -2030, (US$ Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
- Market Size and Forecast, Y-o-Y Growth, By Product Type, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth, By Application, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth, By End User, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth, By Country, 2018 - 2030, (US$ Bn)
GCC
Israel
Rest of Middle East
Africa
- Market Size and Forecast, Y-o-Y Growth, By Product Type, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth, By Application, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth, By End User, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth, By Country/Region, 2018 -2030, (US$ Bn)
North Africa
Central Africa
South Africa

9. Competitive Landscape

Company Profiles
- Thermo Fisher Scientific Inc.
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
- Merck KGaA (Sigma-Aldrich)
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
- OriGene Technologies, Inc.
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
- New England Biolabs
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
- Cellecta, Inc.
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
- Agilent Technologies
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
- Applied StemCell, Inc.
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
- Synthego
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
- Genscript
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
- Mirus Bio LLC
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
- Integrated DNA Technologies, Inc.
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
- Mammoth Biosciences, Inc.
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
- Analysts' Views

10. Section

References
Research Methodology
About us and Sales Contact

02-2729-4219

+886-2-2729-4219

License/价格

Crispr 和 Cas Gene 市场：按产品类型、按应用、按最终用户、按地区

Crispr and Cas Gene Market, By Product Type, By Application, By End User, By Region

市场动态

本研究的主要特点

目录

第1章调查目的和假设

第2章市场展望

第3章市场动态、法规及趋势分析

第4章全球 Crispr 和 Cas 基因市场 - COVID-19 疾病的影响分析

第5章全球 Crispr 和 Cas Gene 市场，依产品类型，2018-2030 年

第6章全球 Crispr 和 Cas Gene 市场，按应用划分，2018-2030 年

第7章全球 Crispr 和 Cas Gene 市场，按最终用户划分，2018-2030 年

第8章2018-2030年全球Crispr和Cas Gene市场（按地区）

第9章竞争形势